Summary

Global CPAP devices market size was valued at USD 2.91 billion in 2023 and is projected to reach USD 4.89 billion by 2031, with a CAGR of 6.9% during the forecast period of 2024 to 2031.
Market Segmentation:
Global CPAP Devices Market Segmentation, By Product Type (CPAP Device and Consumable) Modality (Standalone and Portable), End User (Home Care, Hospitals, Private Clinics, and Others), By Countries (U.S., Canada, Mexico, China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Singapore, rest of Asia-Pacific, Germany, France, U.K., Italy, Russia, Spain, Netherlands, Belgium, Switzerland, Turkey, rest of Europe, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, rest of Middle East and Africa)– Industry Trends and Forecast to 2031

Overview of Global CPAP Devices Market Dynamics:

Drivers
• Growing increasing awareness and diagnosis of sleep apnea
• Growing elderly population with susceptibility to sleep disorders
• Integration of CPAP devices with telemedicine platforms
Restraints
• High initial costs of CPAP devices and related accessories
• Side effects and discomfort associated with the use of CPAP devices
Opportunities
• Growth in healthcare facilities and services in emerging economies
• Technological advancements and innovations to improve device
• Favorable insurance reimbursement policies and coverage
Challenges
• Stringent and complex regulations across various regions
• Stiff competition from alternative therapies

Market Players:

The key market players operating in the global CPAP devices market are listed below:

• ResMed
• Koninklijke Philips N.V.
• Fisher & Paykel Healthcare Limited.
• Drive DeVilbiss International
• BMC
• React Health
• Baird Respiratory
• Transcend, Inc.
• Armstrong Medical Ltd
• Nidek Medical India
• Narang Medical Limited
• Morpheus Healthcare
• Löwenstein Medical SE & Co. KG
• The HomeCare Medical Ltd.
• Hunan Beyond Medical Technology Co., Ltd.
• S Technomed (P) Ltd
• BPL Medical Technologies
• Breas Medical AB

ページTOPに戻る

Table of Contents

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 OVERVIEW 20
1.4 LIMITATIONS 21
1.5 MARKETS COVERED 21
2 MARKET SEGMENTATION 24
2.1 MARKETS COVERED 24
2.2 GEOGRAPHICAL SCOPE 25
2.3 YEARS CONSIDERED FOR THE STUDY 26
2.4 CURRENCY AND PRICING 26
2.5 DBMR TRIPOD DATA VALIDATION MODEL 27
2.6 MULTIVARIATE MODELING 30
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 31
2.8 DBMR MARKET POSITION GRID 32
2.9 MARKET END USER COVERAGE GRID 33
2.10 DBMR VENDOR SHARE ANALYSIS 34
2.11 SECONDARY SOURCES 35
2.12 ASSUMPTIONS 36
3 EXECUTIVE SUMMARY 37
4 PREMIUM INSIGHTS 43
5 MARKET OVERVIEW 45
5.1 DRIVERS 47
5.1.1 INCREASING AWARENESS AND DIAGNOSIS OF SLEEP APNEA 47
5.1.2 GROWING ELDERLY POPULATION WITH SUSCEPTIBILITY TO SLEEP DISORDERS 48
5.1.3 INTEGRATION OF CPAP DEVICES WITH TELEMEDICINE PLATFORMS 48
5.2 RESTRAINTS 50
5.2.1 HIGH INITIAL COSTS OF CPAP DEVICES AND RELATED ACCESSORIES 50
5.2.2 SIDE EFFECTS AND DISCOMFORT ASSOCIATED WITH THE USE OF CPAP DEVICES 51
5.3 OPPORTUNITIES 52
5.3.1 GROWTH IN HEALTHCARE FACILITIES AND SERVICES IN EMERGING ECONOMIES 52
5.3.2 TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS TO IMPROVE DEVICE FUNCTIONALITY 53
5.3.3 FAVORABLE INSURANCE REIMBURSEMENT POLICIES AND COVERAGE 53
 
5.4 CHALLENGES 54
5.4.1 STRINGENT AND COMPLEX REGULATIONS ACROSS VARIOUS REGIONS 54
5.4.2 STIFF COMPETITION FROM ALTERNATIVE THERAPIES 55
6 GLOBAL CPAP DEVICES MARKET, BY PRODUCT TYPE 57
6.1 OVERVIEW 58
6.2 CPAP DEVICE 61
6.3 CONSUMABLE 62
7 GLOBAL CPAP DEVICES MARKET, BY MODALITY 63
7.1 OVERVIEW 64
7.2 STANDALONE 67
7.3 PORTABLE 67
8 GLOBAL CPAP DEVICES MARKET, BY END USER 68
8.1 OVERVIEW 69
8.2 HOME CARE 72
8.3 HOSPITALS 72
8.4 PRIVATE CLINICS 73
8.5 OTHERS 73
9 GLOBAL CPAP DEVICES MARKET, BY REGION 74
9.1 OVERVIEW 75
9.2 NORTH AMERICA 78
9.2.1 U.S. 81
9.2.2 CANADA 83
9.2.3 MEXICO 85
9.3 EUROPE 87
9.3.1 GERMANY 90
9.3.2 U.K. 92
9.3.3 FRANCE 94
9.3.4 ITALY 96
9.3.5 SPAIN 98
9.3.6 SWITZERLAND 100
9.3.7 NETHERLANDS 102
9.3.8 RUSSIA 104
9.3.9 BELGIUM 106
9.3.10 TURKEY 108
9.3.11 REST OF EUROPE 110
 
9.4 ASIA-PACIFIC 111
9.4.1 CHINA 114
9.4.2 JAPAN 116
9.4.3 INDIA 118
9.4.4 SOUTH KOREA 120
9.4.5 AUSTRALIA 122
9.4.6 SINGAPORE 124
9.4.7 MALAYSIA 126
9.4.8 THAILAND 128
9.4.9 INDONESIA 130
9.4.10 PHILIPPINES 132
9.4.11 REST OF ASIA-PACIFIC 134
9.5 SOUTH AMERICA 135
9.5.1 BRAZIL 138
9.5.2 ARGENTINA 140
9.5.3 REST OF SOUTH AMERICA 142
9.6 MIDDLE EAST AND AFRICA 143
9.6.1 SOUTH AFRICA 146
9.6.2 SAUDI ARABIA 148
9.6.3 U.A.E. 150
9.6.4 ISRAEL 152
9.6.5 EGYPT 154
9.6.6 REST OF MIDDLE EAST AND AFRICA 156
10 GLOBAL CPAP DEVICES MARKET: COMPANY LANDSCAPE 157
10.1 COMPANY SHARE ANALYSIS: GLOBAL 157
10.2 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 158
10.3 COMPANY SHARE ANALYSIS: EUROPE 159
10.4 COMPANY SHARE ANALYSIS: NORTH AMERICA 160
11 SWOT ANALYSIS 161
12 COMPANY PROFILES 162
12.1 RESMED 162
12.1.1 COMPANY SNAPSHOT 162
12.1.2 REVENUE ANALYSIS 162
12.1.3 COMPANY SHARE ANALYSIS 163
12.1.4 PRODUCT PORTFOLIO 163
12.1.5 RECENT DEVELOPMENTS 168
 
12.2 KONINKLIJKE PHILIPS N.V. 169
12.2.1 COMPANY SNAPSHOT 169
12.2.2 REVENUE ANALYSIS 169
12.2.3 COMPANY SHARE ANALYSIS 170
12.2.4 PRODUCT PORTFOLIO 170
12.2.5 RECENT DEVELOPMENTS 171
12.3 FISHER & PAYKEL HEALTHCARE LIMITED 172
12.3.1 COMPANY SNAPSHOT 172
12.3.2 REVENUE ANALYSIS 172
12.3.3 COMPANY SHARE ANALYSIS 173
12.3.4 PRODUCT PORTFOLIO 173
12.3.5 RECENT DEVELOPMENTS 174
12.4 DRIVE DEVILBISS INTERNATIONAL 175
12.4.1 COMPANY SNAPSHOT 175
12.4.2 COMPANY SHARE ANALYSIS 175
12.4.3 PRODUCT PORTFOLIO 176
12.4.4 RECENT DEVELOPMENTS 177
12.5 BMC. 178
12.5.1 COMPANY SNAPSHOT 178
12.5.2 COMPANY SHARE ANALYSIS 178
12.5.3 PRODUCT PORTFOLIO 179
12.5.4 RECENT DEVELOPMENTS 180
12.6 ACARE TECHNOLOGY CO LTD. 181
12.6.1 COMPANY SNAPSHOT 181
12.6.2 PRODUCT PORTFOLIO 181
12.6.3 RECENT DEVELOPMENTS 181
12.7 ARMSTRONG MEDICAL LTD 182
12.7.1 COMPANY SNAPSHOT 182
12.7.2 PRODUCT PORTFOLIO 182
12.7.3 RECENT DEVELOPMENTS 184
12.8 BPL MEDICAL TECHNOLOGIES 185
12.8.1 COMPANY SNAPSHOT 185
12.8.2 PRODUCT PORTFOLIO 185
12.8.3 RECENT DEVELOPMENTS 186
12.9 BREAS MEDICAL AB 187
12.9.1 COMPANY SNAPSHOT 187
12.9.2 PRODUCT PORTFOLIO 187
12.9.3 RECENT DEVELOPMENTS 187
 
12.10 EVOX GROUP OF COMPANIES 188
12.10.1 COMPANY SNAPSHOT 188
12.10.2 PRODUCT PORTFOLIO 188
12.10.3 RECENT DEVELOPMENTS 188
12.11 HUNAN BEYOND MEDICAL TECHNOLOGY CO., LTD. 189
12.11.1 COMPANY SNAPSHOT 189
12.11.2 PRODUCT PORTFOLIO 189
12.11.3 RECENT DEVELOPMENT 190
12.12 LOWENSTEIN MEDICAL SE AND CO. KG 191
12.12.1 COMPANY SNAPSHOT 191
12.12.2 PRODUCT PORTFOLIO 191
12.12.3 RECENT DEVELOPMENTS 192
12.13 MORPHEUS HEALTHCARE 193
12.13.1 COMPANY SNAPSHOT 193
12.13.2 PRODUCT PORTFOLIO 193
12.13.3 RECENT DEVELOPMENTS 194
12.14 NARANG MEDICAL LIMITED 195
12.14.1 COMPANY SNAPSHOT 195
12.14.2 PRODUCT PORTFOLIO 195
12.14.3 RECENT DEVELOPMENTS 196
12.15 NIDEK MEDICAL INDIA 197
12.15.1 COMPANY SNAPSHOT 197
12.15.2 PRODUCT PORTFOLIO 197
12.15.3 RECENT DEVELOPMENTS 197
12.16 REACT HEALTH 198
12.16.1 COMPANY SNAPSHOT 198
12.16.2 PRODUCT PORTFOLIO 198
12.16.3 RECENT DEVELOPMENTS 199
12.17 SS TECHNOMED (P) LTD 200
12.17.1 COMPANY SNAPSHOT 200
12.17.2 PRODUCT PORTFOLIO 200
12.17.3 RECENT DEVELOPMENTS 201
12.18 TRANSCEND, INC. 202
12.18.1 COMPANY SNAPSHOT 202
12.18.2 PRODUCT PORTFOLIO 202
12.18.3 RECENT DEVELOPMENTS 203
12.19 THE HOMECARE MEDICAL LTD. 204
12.19.1 COMPANY SNAPSHOT 204
12.19.2 PRODUCT PORTFOLIO 204
12.19.3 RECENT DEVELOPMENTS 205
13 QUESTIONNAIRE 206
14 RELATED REPORTS 209